Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$405,992,201
+$134,360,676 QoQ
Shares Held
1,613,385
+29.2% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.87%
of 13F equity value
Holder Rank
#98
of 4,179 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026APG Asset Management N.V. holds $2,708,459,664 across 8 Drug Manufacturers - General names. ABBV ranks #2 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,210,321 | $1,451,695,438 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
1,613,385 | $405,992,201 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,259,422 | $290,335,727 | |
| 4 | AMGN |
Amgen Inc
|
516,533 | $187,046,929 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,197,619 | $151,307,184 | |
| 6 | PFE |
Pfizer Inc
|
4,179,623 | $100,645,321 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,691,386 | $97,457,661 | |
| 8 | BIIB |
Biogen Inc.
|
110,984 | $23,979,203 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $405,992,201 | 1,613,385 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $271,631,525 | 1,248,938 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $258,557,913 | 1,131,594 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $282,510,520 | 1,220,137 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $277,877,409 | 1,497,023 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $378,648,524 | 1,807,219 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $314,324,111 | 1,768,847 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $66,505,932 | 336,773 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $300,344,040 | 1,751,073 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $315,963,713 | 1,735,111 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $283,400,302 | 1,828,743 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $274,648,118 | 1,842,534 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $270,622,854 | 2,008,631 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $328,474,638 | 2,061,082 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $386,996,962 | 2,394,635 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $63,545,482 | 473,478 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $52,821,208 | 344,876 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $44,777,213 | 276,215 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $47,487,488 | 350,720 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $33,183,185 | 307,622 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $41,893,294 | 371,922 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $59,698,372 | 551,639 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $106,352,804 | 992,560 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $148,233,024 | 1,692,351 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $195,704,157 | 1,993,320 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $132,816,236 | 1,743,224 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||